Updates are available Correction dated 2024-07-11
Click to view Correction: https://doi.org/10.1038/s41467-024-50122-5
-
Authors
Rodriguez de los Santos, Miguel
Kopell, Brian H.
Buxbaum Grice, Ariela
Ganesh, Gauri
Yang, Andy
Amini, Pardis
Liharska, Lora E.
Vornholt, Eric
Fullard, John F. https://orcid.org/0000-0001-9874-2907
Dong, Pengfei https://orcid.org/0000-0003-3735-5158
Park, Eric
Zipkowitz, Sarah
Kaji, Deepak A.
Thompson, Ryan C. https://orcid.org/0000-0002-0450-8181
Liu, Donjing https://orcid.org/0000-0002-9520-7789
Park, You Jeong
Cheng, Esther https://orcid.org/0000-0001-7383-2447
Ziafat, Kimia
Moya, Emily https://orcid.org/0000-0002-9097-9050
Fennessy, Brian https://orcid.org/0000-0002-6222-6190
Wilkins, Lillian
Silk, Hannah
Linares, Lisa M.
Sullivan, Brendan
Cohen, Vanessa
Kota, Prashant
Feng, Claudia https://orcid.org/0000-0001-5912-1526
Johnson, Jessica S.
Rieder, Marysia-Kolbe
Scarpa, Joseph
Nadkarni, Girish N. https://orcid.org/0000-0001-6319-4314
Wang, Minghui https://orcid.org/0000-0001-9171-4962
Zhang, Bin
Sklar, Pamela
Beckmann, Noam D. https://orcid.org/0000-0002-4258-1574
Schadt, Eric E.
Roussos, Panos https://orcid.org/0000-0002-4640-6239
Charney, Alexander W. https://orcid.org/0000-0001-8135-6858
Breen, Michael S. https://orcid.org/0000-0002-6739-939X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (5R03AG080170-02, 1R01AG069976-01)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 23 May 2024
First Online: 26 June 2024
Change Date: 11 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-50122-5
Competing interests
: Girish N. Nadkarni is a founder of Renalytix, Pensieve and is a consultant to Renalytix, Heart Test Laboratories and Pensieve. He serves as a scientific advisory board member for Renalytix, Heart Test Laboratories and Pensieve. He also has equity in Renalytix, Pensieve and Verici. He has also consulted for GSK, Reata, Cambridge Capital and GLG consulting. Brian H. Kopell consults and receives consulting fees from Medtronic, Abbott, and Turing Medical. Eric Schadt has equity in, receives a salary for, and is a Corporate Executive Leader for Pathos. He is also a Board of Directors member for Sage Bionetworks and a Board of Directors member for 4YouandMe, a non-profit institute.
